People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With ...

A U.K. court has ruled against Abbott in a trademark infringement case the company had brought over the design of a rival ...

Molecular communications in the bloodstream is a promising area of research, since the bloodstream has the ability to ...

The global Diabetes Drugs Market size was valued at USD 84.65 billion in 2024 and is expected to be worth around USD 177.74 ...

Along the way, the Lexington teen crossed paths not only with Kendrick Lamar, but also Jay-Z, Samuel L. Jackson and Serena Williams.

Byram Healthcare, a leader in home-based care and part of the Owens & Minor (NYSE: OMI) family, recently launched ...

This CGM will track your body's response - Could personalised glucose data inform your body’s metabolism and performance?

Glucotrack has successfully completed its first in-human clinical study for the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein.

These days, many devices are programmed through apps on patients’ phones. But the FDA warns that certain phone settings, such ...

Gonzaga University and the UW School of Medicine hosted Irl Hirsch to lecture about the future of glucose monitoring.

Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...

Medha N. Munshi, MD, a geriatrician and endocrinologist at Beth Israel Deaconess Medical Center, has dedicated her career to ...